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Editorial for “Advances in Biological Mass Spectrometry and Proteomics” 
Biological mass spectrometry has been a key tool in deciphering the post-genomic molecular complexity 
of life.  Together with its applications in proteomics it has pushed the bioanalytical limits further in order 
to satisfy the ever increasing demand for greater sensitivity, accuracy and throughput.  Although 
proteomics had to undergo a period of disappointing progress after its initial ‘hype and hope’ phase, it is 
difficult to ignore the fact that it is the proteins which are the crucial task force and response units of 
biological organisms, and thus advances in protein analysis will be an essential part of learning more 
about their mode of (inter)action.  However, many beginners’ mistakes have been made in proteomics 
and it has become clear that just more and faster is often not the right analytical strategy if the 
important aspects of accuracy, precision and validity are not considered. 
Thus, it is timely that after a period of six years another special issue on mass spectrometry and 
proteomics is now published in Methods.  It can be seen that both the progression to more thoughtful 
approaches in analyzing proteins and the development of improved methods, increasingly towards the 
rather difficult subjects of low-abundant proteins and protein interactions, are becoming well 
established in the proteomic researcher’s mindset.  It is also evident that in addition to protein 
identification, accurate quantification is now of prime concern, something that has often been ignored 
despite its fundamental importance.  Finally, six years is sufficient time for new instrumentation, 
techniques and concepts to emerge. 
This issue starts with some key ideas and thoughts on quantification in proteomics [Brownridge and 
Beynon] followed by three articles applying different quantification approaches to the analysis of the 
serum proteome and phosphoproteome, for which optimal fractionation (enrichment) and dynamic 
range are pivotal as low-abundant proteins are the target [Sinclair and Timms; Montoya et al.; Dephoure 
and Gygi].  The next contribution provides a review discussing the various steps in deciding upon an 
analytical strategy for quantitative protein-protein interaction (PPI) analysis by mass spectrometry and 
includes an example protocol for quantitative PPI analysis using SILAC and mass spectrometry [Paul et 
al.].  This is followed by two contributions addressing the specific purification of membrane proteins and 
protein-binding partners, respectively [Mathias et al.; Rees and Lilley].  These and the subsequent 
articles are less concerned about quantification than about new methods and technologies for the 
identification and characterisation of proteins, often under conditions that – due to the subject 
protein(s), the cellular environment, or the lack of pre-analytical data (e.g. from protein databases) – are 
challenging and typically demand novel tools of analysis.  Here, the first article addresses a topic that 
has been on the proteomic agenda for some time, single-cell analysis [Koroleva and Cramer].  It is shown 
that current proteomics tools are well capable of detecting cell-specific protein sets from single-cell 
samples.  The emerging concept of peptide identification by searching MS/MS spectral libraries is 
described next and compared to MS/MS data searching using sequence databases, critically evaluating 
its advantages and drawbacks [Lam and Aebersold].  Following this article two emerging issues that 
require de novo gene and structure annotation are addressed.  As next-generation sequencers facilitate 
the sequencing of an increasing number of new genomes, tools that improve gene annotation and 
enable function prediction of novel gene products also need to be established.  Proteogenomics in 
combination with in silico structure prediction using proteomic data is certainly one avenue that could 
effectively fill this wide gap in knowledge with respect to the expression of unknown gene products 
[Bindschedler et al.].  Finally, the last two articles focus on a technique that has recently entered the 
proteomics arena, ion mobility.  While ion mobility has been around for some time it was only in the last 
five years that the technology matured to the point of providing sufficient performance for proteomic 
analyses and its availability through commercial instrumentation.  The first of these two articles 
describes the hyphenation of ion mobility with MALDI mass spectrometry imaging, another techniques 
that has undergone an enormous development in proteomics in the last five years [Cole et al.], while the 
second article provides a review of ion mobility for peptide analysis [Harvey et al.]. 
As can be seen from the variety of topics covered by this issue, proteomics is an active and flourishing 
research field and well aware of the challenges ahead – from the fundamental aspects of quantification 
and accuracy to the challenges of the hidden proteomes and the proteomes of newly sequenced 
organisms.  Clearly, biological mass spectrometry and proteomics still have a long way to go and likewise 
have the capacity to contribute enormously to the life sciences.  Whether there will be real alternatives 
to biological mass spectrometry providing equally high sensitivity, fast analysis and analytical versatility 
remains to be seen.  In any case, proteomics will remain essential in understanding the molecular 
processes of cells and organisms, and biological mass spectrometry will certainly play a crucial role in 
this endeavour for the foreseeable future. 
